NXTC
Price
$4.85
Change
-$0.09 (-1.82%)
Updated
Sep 5 closing price
Capitalization
12.98M
54 days until earnings call
SRPT
Price
$18.71
Change
+$0.25 (+1.35%)
Updated
Sep 5 closing price
Capitalization
1.96B
53 days until earnings call
Interact to see
Advertisement

NXTC vs SRPT

Header iconNXTC vs SRPT Comparison
Open Charts NXTC vs SRPTBanner chart's image
NextCure
Price$4.85
Change-$0.09 (-1.82%)
Volume$4.98K
Capitalization12.98M
Sarepta Therapeutics
Price$18.71
Change+$0.25 (+1.35%)
Volume$5.18M
Capitalization1.96B
NXTC vs SRPT Comparison Chart in %
Loading...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NXTC vs. SRPT commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NXTC is a Hold and SRPT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (NXTC: $4.85 vs. SRPT: $18.71)
Brand notoriety: NXTC: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NXTC: 3% vs. SRPT: 36%
Market capitalization -- NXTC: $12.98M vs. SRPT: $1.96B
NXTC [@Biotechnology] is valued at $12.98M. SRPT’s [@Biotechnology] market capitalization is $1.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NXTC’s FA Score shows that 1 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • NXTC’s FA Score: 1 green, 4 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, NXTC is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NXTC’s TA Score shows that 3 TA indicator(s) are bullish while SRPT’s TA Score has 5 bullish TA indicator(s).

  • NXTC’s TA Score: 3 bullish, 4 bearish.
  • SRPT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than NXTC.

Price Growth

NXTC (@Biotechnology) experienced а -3.58% price change this week, while SRPT (@Biotechnology) price change was +2.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

NXTC is expected to report earnings on Oct 30, 2025.

SRPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($1.96B) has a higher market cap than NXTC($13M). NXTC YTD gains are higher at: -47.579 vs. SRPT (-84.612). SRPT has higher annual earnings (EBITDA): 36.1M vs. NXTC (-61.2M). SRPT has more cash in the bank: 800M vs. NXTC (35.3M). NXTC has less debt than SRPT: NXTC (4.67M) vs SRPT (1.35B). SRPT has higher revenues than NXTC: SRPT (2.48B) vs NXTC (0).
NXTCSRPTNXTC / SRPT
Capitalization13M1.96B1%
EBITDA-61.2M36.1M-170%
Gain YTD-47.579-84.61256%
P/E RatioN/A27.21-
Revenue02.48B-
Total Cash35.3M800M4%
Total Debt4.67M1.35B0%
FUNDAMENTALS RATINGS
NXTC vs SRPT: Fundamental Ratings
NXTC
SRPT
OUTLOOK RATING
1..100
862
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
8966
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NXTC's Valuation (12) in the Biotechnology industry is somewhat better than the same rating for SRPT (57). This means that NXTC’s stock grew somewhat faster than SRPT’s over the last 12 months.

NXTC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that NXTC’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's SMR Rating (93) in the Biotechnology industry is in the same range as NXTC (100). This means that SRPT’s stock grew similarly to NXTC’s over the last 12 months.

SRPT's Price Growth Rating (66) in the Biotechnology industry is in the same range as NXTC (89). This means that SRPT’s stock grew similarly to NXTC’s over the last 12 months.

SRPT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as NXTC (100). This means that SRPT’s stock grew similarly to NXTC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NXTCSRPT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 25 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 5 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUBS487.5323.22
+5.00%
HUBSPOT
BHAT1.740.07
+4.20%
Blue Hat Interactive Entertainment Technology
RDNW3.940.12
+3.14%
RideNow Group Inc
SAND11.480.26
+2.32%
Sandstorm Gold Ltd
LVWR3.54-0.07
-1.94%
LiveWire Group

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with ACET. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
-1.82%
ACET - NXTC
35%
Loosely correlated
+1.00%
SRPT - NXTC
31%
Poorly correlated
+1.35%
RARE - NXTC
30%
Poorly correlated
+1.73%
OKYO - NXTC
28%
Poorly correlated
+0.44%
LEGN - NXTC
27%
Poorly correlated
+3.12%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with BPMUF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+1.35%
BPMUF - SRPT
52%
Loosely correlated
N/A
AAVXF - SRPT
45%
Loosely correlated
+15.45%
BHVN - SRPT
37%
Loosely correlated
-1.24%
ROIV - SRPT
36%
Loosely correlated
+2.78%
SNDX - SRPT
36%
Loosely correlated
+5.25%
More